11.   Bristol-Myers Squibb Co. has yet to overcome the blow it took when sales of heart drug Capoten plummeted after its patent expired last year.

12.   Bristol-Myers will market the new heart drug in the U.S. next year, said company spokesman Robert Laverty.

13.   Centocor Inc. said the U.S. Food and Drug Administration approved its heart drug ReoPro for preventing complications in two key new groups of patients.

14.   Earlier this morning, Genentech told the panel that its blockbuster heart drug Activase can also provide hope for patients suffering from ischemic stroke.

15.   Finally, the company is working on a heart drug known as moxonidine which is being developed to treat high blood pressure and congestive heart failure.

16.   Genentech Inc. told a Food and Drug Administration panel this morning that its blockbuster heart drug Activase can also provide hope for patients suffering from ischemic stroke.

17.   Genentech Inc. will get a look at the competition to its blockbuster heart drug Activase next week at the annual American College of Cardiology conference in Anaheim, California.

18.   He also helped develop a way to measure concentrations of two widely used heart drugs, digoxin and digitoxin, in the blood.

19.   He studied digoxin, a common heart drug of the digitalis family, found in the foxglove plant, whose beneficial nature was known in antiquity.